Journal article

Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart

JR Bell, P Eaton, MJ Shattock

Clinical and Experimental Pharmacology and Physiology | WILEY | Published : 2008

Abstract

1. Activation of p38-mitogen-activated protein kinase (MAPK) has been implicated in the signalling cascade leading to protection by ischaemic preconditioning. This, however, is controversial and there is a plethora of conflicting data in the literature. Although many experimental differences may contribute to this, two in particular may be confounding: (i) the failure to account for p38-MAPK activation during aerobic perfusion; and (ii) the use of the anti-oxidant dimethylsulphoxide (DMSO) as the vehicle for the commonly used p38-MAPK inhibitor SB203580. We have investigated the effects of aerobic perfusion, ischaemia and preconditioning on p38-MAPK activation. In addition, we have used wate..

View full abstract

University of Melbourne Researchers